Early studies showed that pp32, through a specific domain comprised of ∼25 amino acids, acted like a tumor suppressor by inhibiting K-ras, a mutant p53, c-jun, E1A, E6, and E7 [12], [13]. The gene discussed is KRAS; the disease is neoplasm.